Copper Cu 64 trastuzumab
Term · Oncology and biomedicine · MLC-T-ONC-012753
A diagnostic radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody trastuzumab conjugated with the positron-emitting radioisotope copper Cu 64. Copper Cu 64 trastuzumab binds to the extracellular domain of human epidermal growth factor receptor 2 (HER2), allowing the detection of HER2 distribution using positron emission tomography (PET).
| Identifier | MLC-T-ONC-012753 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Cu-64-trastuzumab |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012753",
"term": "Copper Cu 64 trastuzumab",
"field": "Oncology and biomedicine",
"definition": "A diagnostic radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody trastuzumab conjugated with the positron-emitting radioisotope copper Cu 64. Copper Cu 64 trastuzumab binds to the extracellular domain of human epidermal growth factor receptor 2 (HER2), allowing the detection of HER2 distribution using positron emission tomography (PET).",
"synonyms": [
"Cu-64-trastuzumab"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/copper-cu-64-trastuzumab/"
}
Record 5,302 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.